Showing results (1651-1660 of 3,660) with videos related to

Sort By:
Pageof 366
Breast (Edinburgh, Scotland)|June 22, 2025
High impact of chemotherapy on ovarian reserve in breast cancer survivors of reproductive age: A systematic review and meta-analysisSusanna Weidlinger, Magdalena Weidlinger, Rose-Maria Schramm, et al.
Breast (Edinburgh, Scotland)|June 26, 2025
Integrating genetic polymorphisms and clinical data to develop predictive models for skin toxicity in breast cancer radiation therapyEster Aguado-Flor, Victoria M Reyes, Víctor Navarro, et al.
Breast (Edinburgh, Scotland)|June 20, 2025
Hyaluronic acid 0.2 % cream for preventing radiation dermatitis in breast cancer patients treated with postoperative radiotherapy: A randomized, double-blind, placebo-controlled studyLetizia Deantonio, Giulia Borgonovo, Serena Caverzasio, et al.
Breast (Edinburgh, Scotland)|December 13, 2025
Omission of sentinel lymph node biopsy in early stage luminal breast cancer: impact on adjuvant CDK4/6 inhibitor recommendation and oncological outcomesMartin Heidinger, Tibor A Zwimpfer, Florian S Halbeisen, et al.
Breast (Edinburgh, Scotland)|February 8, 2026
Impact of axillary disease extent defined by baseline 18F-FDG PET/CT on the accuracy of axillary surgical staging after neoadjuvant systemic therapy in clinically node-positive breast cancerCornelis M de Mooij, Janine M Simons, Florien J G van Amstel, et al.
Breast (Edinburgh, Scotland)|December 19, 2025
Comparative validation of PREDICT versions 3.1 and 2.2 for overall survival in the Dutch breast cancer populationLara W A Vreven, Elfi M Verheul, Marissa C van Maaren, et al.
Breast (Edinburgh, Scotland)|December 11, 2025
Validation of a deep learning-based AI model for breast cancer risk stratification in postmenopausal ER+/HER2-breast cancer patientsSandra Sinius Pouplier, Abhinav Sharma, Pekka Ruusuvuori, et al.
Breast (Edinburgh, Scotland)|December 3, 2025
Less endocrine therapy in HR+/HER2- breast cancer: a nationwide trend despite unchanged guidelinesEline E F Verreck, Emily L Postma, Tanja Oostergo, et al.
Breast (Edinburgh, Scotland)|November 28, 2025
Outcomes for ER-positive CHEK2 c.1100delC breast cancer patients compared with breast cancer patients without the variantMaartje A C Schreurs, Muriel A Adank, Bernadette A M Heemskerk-Gerritsen, et al.
Breast (Edinburgh, Scotland)|February 14, 2025
Characteristics and prognosis of patients with primary metastatic disease vs. recurrent HER2-negative, hormone receptor-positive advanced breast cancerChristina B Walter, Andreas D Hartkopf, Alexander Hein, et al.
Pageof 366